Consultant Ophthalmologist, Chief Medical Officer, Strategic Healthcare Advisor

At the intersection of clinical expertise, digital innovation, and healthcare investment, Dr. Marko Lukic brings a rare dual perspective as both a frontline ophthalmologist and a strategic advisor to pioneering healthcare/healthtech ventures. Internationally trained and having served as a consultant ophthalmologist at Moorfields Eye Hospital NHS Foundation Trust in London, he leverages over a decade of clinical, academic, and commercial experience to drive transformative change in healthcare.

Dr. Lukic is the founder of European Medical Consultants, where he advises startups on business strategy, clinical adoption, clinical protocol development, and go-to-market execution. He has collaborated with Google DeepMind on AI-driven projects in ophthalmology and advised companies including Ascento CDA, Specsavers, Eclevar MedTech, Eys, I-Care, and Vision Ventures VC. He has also contributed to board-level strategic discussions with top companies, including Topcon Healthcare, Roche, and Bayer. In parallel, Dr. Lukic works closely with investors, helping them identify high-potential opportunities in healthtech and guiding portfolio companies in building partnerships, raising capital, and entering new markets.

As Chief Medical Officer at Ascento CDA, Dr. Lukic leads the clinical and scientific direction of AI-powered solutions for early detection of cognitive decline while also steering market expansion across Europe and Southeast Asia.

An active healthcare investor, Dr. Lukic is affiliated with investor networks, including VNTR and the London VC Network. He is a regular invited speaker at global ophthalmology conferences, including EURETINA, ASRS, and ARVO.

With a professional network spanning the UK, EU, Middle East, and Asia, Dr. Lukic serves as a connector between cutting-edge medical technologies, strategic partnerships, and capital. He brings proven experience in both clinical innovation and health tech advisory and is committed to accelerating the next generation of impactful, patient-focused healthcare solutions. His dual expertise enables family offices and mission-driven investors to allocate capital toward healthcare innovations with measurable impact and reduced risk.